Compliance, common errors and auto-medication

Resistance is usually described as a property of bacteria, but it is produced by a process that involves the patient’s behaviour. When an antibiotic is taken at the right dose for the full duration, the concentration in the body stays high enough for long enough to kill the susceptible organisms, and the infection is controlled. When the course is stopped early, the concentration falls while some organisms are still alive. Those survivors are the ones that were least affected — either naturally less susceptible or already carrying a resistance mechanism — and they now multiply in a body with no drug pressure. The result is a population that is harder to treat than the original infection, and, because bacteria exchange genetic material, resistance can move to other species as well. This is why “feeling better” is not a safe signal to stop: the symptom reflects the reduction in the bacterial population, not its elimination. It also explains why the same course must be completed even when the illness is mild, and why a leftover antibiotic used later for a different infection is doubly risky: the drug may not match the organism, and the partial exposure selects for resistance a second time. The individual decision and the public consequence are therefore the same event seen at two scales.

A look-alike or sound-alike error happens when two different medicines share enough letters or sounds that a reader or listener supplies the wrong one. The mechanism is ordinary human perception: the eye and the ear do not read every character, they recognise a pattern and complete it from expectation, and expectation is shaped by the setting. A prescriber who has just seen three patients with the same condition is primed for the drug used for that condition; a tired dispenser reaching for a familiar shelf may pick up the neighbouring box. Because the cause is systemic rather than personal, the defences are systemic too. Tall-man lettering deliberately changes the visual pattern by highlighting the differing syllables, so the two products no longer look like the same word. Storing look-alike products apart, and never alphabetically adjacent, removes the physical proximity that makes the wrong reach easy. Read-back and independent double-checks for high-risk medicines interrupt the expectation before it becomes an action. Confirming at least two patient identifiers prevents the same recognition error from being applied to the wrong person. Barcoding and computerised order entry catch the mismatch at the point of scanning. None of these measures asks people to be more careful; each one changes the environment so that the natural error cannot complete itself. That is the general lesson of medication safety: design the system for the human being who will actually use it, not for the one who never gets tired.